Instil Bio News

H.C. Wainwright Maintains Instil Bio(TIL.US) With Buy Rating, Maintains Target Price $110

Futu NewsNov 19 16:39

Strategic Acquisitions and Market Potential Position Instil Bio's SYN-2510 as a Buy With High Growth Prospects

TipRanksNov 18 19:32

H.C. Wainwright Maintains Instil Bio(TIL.US) With Buy Rating, Cuts Target Price to $110

Futu NewsNov 14 19:31

Instil Bio Analyst Ratings

BenzingaNov 14 19:29

HC Wainwright & Co. Maintains Buy on Instil Bio, Lowers Price Target to $110

BenzingaNov 14 19:29

JMP Securities Maintains Instil Bio(TIL.US) With Hold Rating

Futu NewsNov 14 13:31

JMP Securities Initiates Instil Bio(TIL.US) With Hold Rating

Futu NewsNov 4 18:32

Instil Bio Analyst Ratings

BenzingaNov 4 18:05

Baird Maintains Instil Bio(TIL.US) With Buy Rating, Maintains Target Price $180

Futu NewsOct 30 21:43

Baird Maintains Instil Bio(TIL.US) With Buy Rating, Maintains Target Price $180

Futu NewsOct 12 06:32

Baird Maintains Instil Bio(TIL.US) With Buy Rating, Maintains Target Price $180

Futu NewsSep 20 18:35

H.C. Wainwright Maintains Instil Bio(TIL.US) With Buy Rating, Maintains Target Price $120

Futu NewsSep 17 18:35

Instil Bio Is Maintained at Buy by HC Wainwright & Co.

Dow JonesSep 17 01:35

Instil Bio Price Target Raised to $120.00/Share From $40.00 by HC Wainwright & Co.

Dow JonesSep 17 01:35

Baird Maintains Instil Bio(TIL.US) With Buy Rating, Maintains Target Price $180

Futu NewsSep 16 23:31

Baird Reiterates Outperform on Instil Bio, Maintains $180 Price Target

BenzingaSep 16 22:24

H.C. Wainwright Maintains Instil Bio(TIL.US) With Buy Rating, Raises Target Price to $120

Futu NewsSep 16 18:33

Instil Bio Price Target Raised to $180.00/Share From $32.00 by Baird

Dow JonesSep 14 01:56

Instil Bio Is Maintained at Outperform by Baird

Dow JonesSep 14 01:56

Baird Maintains Instil Bio(TIL.US) With Buy Rating, Raises Target Price to $180

Futu NewsSep 13 18:32